Sala de prensa de HARTMANN

Sales and raw material markets remain challenging, but general conditions have stabilized for the first time compared to the previous year. The positive effects of the HARTMANN GROUP's Transformation Program again contributed to an increase in earnings. The Company implemented cost-saving measures in freight and logistics concepts. Product…

Successful product launches and the acquisition of new customers, as well as the focused, continued implementation of the Transformation Program, had a positive impact on HARTMANN's business development in the first quarter of 2024. The Company was once again able to demonstrate its resilience in a difficult market environment with material costs…

The various commercial and geopolitical challenges during the reporting year had a significant impact on the business performance of the HARTMANN GROUP. HARTMANN continued to operate in a difficult market environment in 2023 with reduced demand persisting in the markets – partly due to a massive shortage of personnel in the European healthcare…

At EUR 203 million, adjusted EBITDA was at the upper end of the earnings forecast of EUR 180 to 210 million, which had been increased in November. The previous year's result was thus exceeded by EUR 12 million. The Company was able to more than compensate for massive additional material, energy and freight costs of almost EUR 80 million. This was…

The HARTMANN GROUP expects moderate organic sales growth and adjusted EBITDA in the range of EUR 200 to 240 million for the 2024 financial year. This represents an increase compared to the last earnings forecast for 2023 of EUR 180 to 210 million.

Oliver Neubrand will be the new CFO of the HARTMANN GROUP. He will resume responsibility on January 1, 2024, and will be responsible for Controlling, Finance, Accounting, Mergers & Acquisition, Risk Management, Legal, IT, Investor Relations and the businesses CMC and IVF HARTMANN in Switzerland.

From January to September 2023, the HARTMANN GROUP generated sales revenues of EUR 1,747.2 million. This corresponds to organic sales growth of 2.5% compared to the same period of the previous year.

PAUL HARTMANN AG has been nominated for the German Sustainability Award in the field of medical technology. Honoring companies for their sustainability achievements, the award is being given this year for the 16th time by the German Sustainability Award Foundation in cooperation with the German government.